Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC)
- Authors:
- A Oaknin, A Oza, AV Tinker, I Ray-Coquard, R Coleman, D O'Malley, R Shapira-Frommer, A Leary, LM Chen, D Provencher, L Ma, J Brenton, J Balmana, H Giordano, L Maloney, S Goble, L Rolfe, I McNeish, E Swisher, RS Kristeleit
- Journal:
- European Journal of Cancer
- Citation info:
- 72:S95-S95
- Publication date:
- 1st Feb 2017
- Full text
- DOI